Literature DB >> 32565383

Association of Retinal Microvascular Signs with Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Gen-Min Lin1, Laura A Colangelo2, Barbara E K Klein3, Mary Frances Cotch4, Tien Y Wong5, Carol Y Cheung6, Susan R Heckbert7, Alvaro Alonso8, Younghoon Kwon9, Richard A Kronmal10, Donald M Lloyd-Jones2, Kiang Liu2.   

Abstract

PURPOSE: Microvascular diseases may contribute to the occurrence of atrial fibrillation (AF). Retinal microvascular signs that are similar to other microvasculature in the body and can be visualized directly via ophthalmoscopy may provide insights into such a relationship.
DESIGN: Prospective, longitudinal, multiethnic study. PARTICIPANTS: We examined the association between retinal microvascular signs and incident AF in 4994 participants 47 to 86 years of age and free of prior AF who underwent fundus photography from 2002 through 2004 and were followed up through 2015 in the Multi-Ethnic Study of Atherosclerosis (MESA).
METHODS: Retinal microvascular signs evaluated include central retinal arteriolar equivalent and central retinal venular equivalent (CRVE) and presence of any retinopathy signs (e.g., retinal microaneurysms or hemorrhages). A multivariate Cox regression analysis was used to determine the relationship while adjusting for traditional risk factors, alcohol intake, body mass index, diabetes status, chronic kidney disease status, hemoglobin A1c level, C-reactive protein level, medications, and prevalent cardiovascular diseases or heart failure. MAIN OUTCOME AND MEASURES: Incident AF events were identified using 12-lead electrocardiographic findings, hospital discharge records, and Medicare claims data.
RESULTS: During a median follow-up of 14.1 years, 643 AF events were identified. No association was found between any retinal microvascular signs and incident AF except for retinal focal arteriolar narrowing (hazard ratio, 1.75; 95% confidence interval, 1.06-2.87) in the overall population. However, in the subgroup analyses by gender, wider CRVE was associated with a higher risk of incident AF in women, but not in men (hazard ratio for every 10-μm increase in CRVE, 1.08 [95% confidence interval, 1.01-1.15] and 0.97 [95% confidence interval, 0.92-1.03], respectively; P = 0.041 for interaction).
CONCLUSIONS: No consistent pattern of association was found between retinal microvascular signs and incident AF. We observed an association in women, but not in men, of wider retinal venular calibers with incidence of AF. The reasons for a possible interaction are incompletely understood.
Copyright © 2020 American Academy of Ophthalmology. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32565383      PMCID: PMC9371614          DOI: 10.1016/j.oret.2020.06.019

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN: 2468-6530


  41 in total

1.  Gender differences in cutaneous laser doppler flow response to local direct and contralateral cooling.

Authors:  K Cankar; Z Finderle; M Strucl
Journal:  J Vasc Res       Date:  2000 May-Jun       Impact factor: 1.934

2.  Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Gen-Min Lin; Laura A Colangelo; Donald M Lloyd-Jones; Susan Redline; Joseph Yeboah; Susan R Heckbert; Saman Nazarian; Alvaro Alonso; David A Bluemke; Naresh M Punjabi; Moyses Szklo; Kiang Liu
Journal:  Am J Epidemiol       Date:  2015-05-13       Impact factor: 4.897

3.  Retinal microvascular signs and risk of stroke and stroke mortality.

Authors:  P Mitchell; J J Wang; T Y Wong; W Smith; R Klein; S R Leeder
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

Review 5.  Some thoughts on the vasculopathy of women with ischemic heart disease.

Authors:  Carl J Pepine; Richard A Kerensky; Charles R Lambert; Karen M Smith; Gregory O von Mering; George Sopko; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

6.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

7.  Determinants of retinal venular diameter: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Tien Y Wong; Barbara E K Klein
Journal:  Ophthalmology       Date:  2012-08-20       Impact factor: 12.079

8.  Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis.

Authors:  Ning Cheung; A Richey Sharrett; Ronald Klein; Michael H Criqui; F M Amirul Islam; Katarzyna J Macura; Mary Frances Cotch; Barbara E K Klein; Tien Y Wong
Journal:  Hypertension       Date:  2007-08-13       Impact factor: 10.190

9.  Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis.

Authors:  Ning Cheung; David A Bluemke; Ronald Klein; A Richey Sharrett; F M Amirul Islam; Mary Frances Cotch; Barbara E K Klein; Michael H Criqui; Tien Yin Wong
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

10.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Authors:  Renate B Schnabel; Xiaoyan Yin; Philimon Gona; Martin G Larson; Alexa S Beiser; David D McManus; Christopher Newton-Cheh; Steven A Lubitz; Jared W Magnani; Patrick T Ellinor; Sudha Seshadri; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin; Daniel Levy
Journal:  Lancet       Date:  2015-05-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.